Rosacea is a chronic inflammatory skin disease associated with dilation of facial blood vessels. It affects about 10% of people in the 30-50 year age range. It is more common in women and people with light skin. Severe rosacea is relatively rare and affects mainly men. The disease’s typical symptoms are diffuse redness of cheeks, chin, nose and forehead, sometimes accompanied by swelling, burning sensation, itchiness, visibly dilated capillaries or eye irritation. Rosacea passes through several stages that require targeted treatment.

A combination of topical agents, procedures, medication, specialised cosmetics and changes in the patient’s habits are at the core of controlling rosacea. Making an early and accurate scanner diagnosis is extremely important. A high-quality 3D image is used to examine deep skin layers – dilated blood vessels, pores, hidden pigmentation, and hydration by area and other parameters. Using the latest generation laser technology, visible dilated capillaries and diffuse reddening caused by the disease are treated with great precision. The choice of treatment is strongly individual for each patient and is made according to the stage of rosacea.

More information

The main reason for this disease is genetic predisposition. Other factors include the immune response to Bacillus oleronius in people suffering from rosacea and untreated infection with Helicobacter pylori, which results in more frequent flare-ups. It has also been established that Demodex folliculorum (microscopic mite), which inhabits sebaceous hair follicles in the cheek and nose area, plays a part in developing rosacea. In recent years, Cathelicidin – a protein leading to the appearance of redness and swelling – has also been implicated.


Stages of rosacea
Subtype 1: Erythematotelangiectatic rosacea
Characterised by episodes of flushing of the central part of the face, visibly dilated blood vessels, sensitivity, burning sensation and swelling of the skin. Dryness, roughness and desquamation are observed very often.
Subtype 2: Papulopustular rosacea
At the second stage, periodically activated changes similar to acne are added to the diffuse flushing of the skin. The skin is greasy, with high sensitivity and a burning sensation. Visibly dilated capillaries and plaques appear on the face.
Subtype 3: Phymatous rosacea
This rare phase is characterised by visible thickening of the skin on the face and dilated capillaries. The skin is greasy, with dilated pores. The severe form is the so-called rhinophyma – enlargement of the nasal tissues.
Subtype 4: Occular rosacea
Years ago, it was believed that occular rosacea is a complication of the severe forms of the disease. Today, occular rosacea is accepted as a separate condition that only affects the eyes and does not cause changes in the skin on the face. Patients feel irritation, a burning sensation, dryness and itchiness in the eyes.






  • Clinical studies
  • Machine-assisted diagnostic assessments
  • Medicinal treatment
  • Specialised medical cosmetics
  • Machine-assisted procedures
  • Epidermal exfoliation

Recovery period

  • Up to 12 months.


  • Pregnancy
  • Breastfeeding


The period of bringing rosacea under control is strongly individual. There must be strict compliance with the dermatologist’s recommendations on diet, use of cosmetics, medication and order of procedures. Depending on the stage of rosacea, improvements can take up to 12 months to become noticeable, but whether the inflammatory process has been brought under control or not, treatment should continue for another 2 years.

Frequently asked questions:

The dermatologist determines where the filler should be inserted, taking into account the patient’s anatomical features. The procedure lasts around 20-30 minutes.

The filler is spread evenly in the cheekbone area, with the results visible immediately.

No recovery period is required for this procedure. Redness or swelling may appear at the injection site, but the discomfort passes quickly (a few hours to a few days).

The effect is visible immediately and lasts around a year.

The procedure can be repeated again after the filler’s full or partial degradation.

  • Hypersensitivity to various types of fillers;
  • Skin injury at the injection site.